$STLABullishMed

Stellantis and Factorial Integrate Advanced Solid-State Battery into Stellantis Development Vehicle and Launch Road Testing

Stellantis said it has integrated Factorial’s FEST® advanced solid-state battery cells into a Dodge Charger Daytona development vehicle, the first North America automotive integration of the technology, and started road testing to validate performance, safety and reliability. Stellantis and Factorial used a patented mechanical pack architecture and adapted control systems. Factorial previously reported 375 Wh/kg energy density and 15%–90% charging in 18 minutes.

7/10
7/10
Med
Bullish
Road testing program launched immediately (June 11, 2026)
Generally risk-reducing for solid-state commercialization; aligns with bullish EV battery-tech narratives

Road-testing milestone de-risks solid-state commercialization path for Stellantis and can improve investor confidence in EV tech roadmap execution.

Stellantis integrated Factorial’s FEST solid-state cells into a Dodge Charger Daytona development vehicle and started road testing to validate safety and reliability.

Modest positive bias; near-term impact likely limited unless follow-on milestones (validation results, scale/production timeline) are disclosed.

Background

Stellantis and Factorial previously validated automotive-scale FEST cells; this release reports the first vehicle integration in North America and the start of road testing for a Dodge Charger Daytona development vehicle.

Why it matters

The milestone transitions FEST from cell testing to system-level validation in a real vehicle, which can reduce technical risk but still requires road-test results and calibration outcomes to translate into commercial traction.

Market relevance

Traders may view this as a de-risking step for solid-state battery commercialization, but the lack of quantified road-test results or commercial terms limits immediate fundamental repricing.

Market effects

Adds a tangible validation datapoint for solid-state battery commercialization, potentially improving read-across sentiment for the solid-state supply chain and EV battery R&D.

North America integration/road testing may increase regional investor focus on domestic solid-state development and partnerships.

Supports the global shift toward higher energy density and faster charging; could influence competitive positioning among battery technology developers.

Alternative perspectives

Road testing is early-stage; without disclosed performance outcomes, safety findings, or production commitments, the market may fade the news after initial enthusiasm.

Key missing items are (1) whether the pack meets automotive durability targets over time, (2) manufacturability/scale economics beyond compatibility claims, and (3) any binding commercial terms (volume, pricing, timeline) tied to the milestone.

Key entities

  • Stellantis

    Integrated Factorial’s FEST solid-state cells into a development vehicle and began road testing to verify performance, safety, and reliability.

  • Factorial Energy

    Provided FEST solid-state battery cells and FEST®/Solstice™ platforms; road testing started after vehicle integration.

  • Dodge Charger Daytona

    The specific Stellantis development vehicle used for integrating and road-testing FEST solid-state cells.

Related articles

$MBG.DEMed

Set-back for Mums for Lungs in Dieselgate battle

UK High Court delivered a mixed verdict in a group action over alleged diesel emissions defeat devices. According to the court, most principal allegations against Mercedes-Benz, Ford, Renault, Nissan and Stellantis-owned Peugeot-Citroën were rejected, but adverse findings were made for Mercedes (coolant temperature setpoint) and Peugeot-Citroën (split-injection). A further damages trial is set for Oct 2026 for 1.6 million motorists.

$STLAMed

Stellantis (NYSE: STLA), Ollie’s Bargain Outlet (NASDAQ: OLLI), And NuScale Power (NYSE: SMR) Crash To 52-Week Lows On Growth And Cost Fears

Stellantis (STLA), Ollie’s Bargain Outlet (OLLI), and NuScale Power (SMR) hit fresh 52-week lows on growth and cost worries. Stellantis fell to $5.33 despite 6% YoY Q2 U.S. sales growth; JPMorgan cut its STLA target to $6.85. OLLI dropped to $61.61; JPMorgan cut its target to $70 and lowered Q2 EPS/sales. SMR fell to $8.55 after a larger-than-expected Q1 loss and 96% revenue decline.

$AZNMed

Stocks making the biggest moves premarket: AstraZeneca, PepsiCo, Salesforce, Levi & more

Premarket movers included AstraZeneca, down 8% after its heart disease drug Wainua missed a late-stage trial target. PepsiCo fell 1% after Q2 adjusted EPS of $2.20 missed $2.21 consensus, while revenue beat. Salesforce and Stellantis slid on downgrades. Levi dropped on weaker Q3 guidance. AZZ rose on earnings and revenue beats; Cerebras gained on European expansion; Costco fell on slower June comps.

$VOW3.DEMed

German auto lobby chief warns of deeper industry job cuts

Germany’s VDA industry chief Hildegard Müller told Bloomberg that Europe’s auto sector faces further restructuring, including additional job cuts and plant closures, to remain competitive. She linked the outlook to Volkswagen’s current problems and cited high energy and labor costs and regulatory pressure. The article also notes VW is reportedly considering closing four German factories and cutting up to 100,000 jobs, and SAIC Motor plans a €200m plant in Spain targeting 120,000 vehicles annuall

$STLAMed

Jeep's parent stock has underperformed. JPMorgan doesn't see an improvement in the near future

JPMorgan downgraded Stellantis (STLA) to neutral from overweight, saying the automaker’s turnaround will take about 14 months to reflect lower component costs in product launches in FY27/28. The investment case depends on North American operations affected by destocking and price repositioning. JPMorgan expects a slow Q2 and near break-even margins, with moderate earnings progress into FY27/28. Shares are down 50% YTD.